Why the study?
The renin-angiotensin system is heavily involved in the pathogenesis of long COVID, but a comprehensive summary of its impact across multiple organs, risk factors, and potential therapeutic approaches was needed.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Long COVID's multisystem effects warrant clinical vigilance; leaves open precise mechanisms and targeted interventions for prospective trials.
COVID-19 has expanded across the world since its discovery in Wuhan (China) and has had a significant impact on people's lives and health. Long COVID is a term coined by the World Health Organization (WHO) to describe a variety of persistent symptoms after acute SARS-CoV-2 infection. Long COVID has been demonstrated to affect various SARS-CoV-2-infected persons, independently of the acute disease severity. The symptoms of long COVID, like acute COVID-19, consist in the set of damage to various organs and systems such as the respiratory, cardiovascular, neurological, endocrine, urinary, and immune systems. Fatigue, dyspnea, cardiac abnormalities, cognitive and attention impairments, sleep disturbances, post-traumatic stress disorder, muscle pain, concentration problems, and headache were all reported as symptoms of long COVID. At the molecular level, the renin-angiotensin system (RAS) is heavily involved in the pathogenesis of this illness, much as it is in the acute phase of the viral infection. In this review, we summarize the impact of long COVID on several organs and tissues, with a special focus on the significance of the RAS in the disease pathogenesis. Long COVID risk factors and potential therapy approaches are also explored.
No takes yet. Share an insight, caveat, or question.
Khazaal et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: